Information de reference pour ce titreAccession Number: | 00003184-199610000-00008.
|
Author: | WOLKENSTEIN, PIERRE 1; CHOSIDOW, OLIVIER 1; FLECHET, MARIE-LAURE 1; ROBBIOLA, ODILE 1; PAUL, MURIEL 2; DUME, LAURENCE 2; REVUZ, JEAN 1; ROUJEAU, JEAN-CLAUDE 1
|
Institution: | Departments of (1)Dermatology and (2)Pharmacy, Hopital Henri-Mondor, Creteil, France
|
Title: | Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.[Article]
|
Source: | Contact Dermatitis. 35(4):234-236, October 1996.
|
Abstract: | Patch testing may help to assess the culpability of a drug in an adverse reaction. Our aim was to study patch testing in severe cutaneous adverse drug reactions (ADRs) (Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), acute generalized exanthematous pustulosis (AGEP), and other cutaneous ADRs). 59 patients with cutaneous ADRs were included: 22 had SJS/TEN, 14 AGEP, and 23 other cutaneous ADRs. Patients were patch tested with the suspect drug, and with a standard series of drugs. 2 patients among the 22 SJS/TEN cases had a relevant positive test. 7 patients among the 14 AGEP cases had a relevant positive test. 6 patients among the 23 other cutaneous ADRs had a relevant positive test. Our results suggest that patch testing has a weak sensitivity in SJS/TEN and is not appropriate in these diseases. Patch testing seems more adapted to other cutaneous ADRs, such as AGEP, in which the proportion of positive patch tests was significantly higher (p<0.02). Nevertheless, the difference of sensitivity of patch testing in SJS/TEN, AGEP or other cutaneous ADRs could be linked not only to the clinical type of eruption, but also to the different spectrum of culprit drugs in each type of eruption.
(C) 1996 Munksgaard International Publishers Ltd.
|
Author Keywords: | patch tests; Stevens-Johnson syndrome; toxic epidermal necrolysis; acute generalized exanthematous pustulosis; cutaneous adverse drug reactions; sulfonamides; anticonvulsants; antibiotics; non-steroidal anti-inflammatory drugs; diltiazem; terfenadine.
|
References: | 1. Roujeau J C, Stern R S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994: 33: 1272-1285.
2. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F. Adverse drug reaction monitoring: Doing it the French way. Lancet 1985: 2: 1056-1058.
3. Montgomery P R. Toxic epidermal necrolysis due to phenylbutazone. Br J Dermatol 1970: 83: 220.
4. Friedmann P S, Strickland I, Pirmohamed M, Park K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994: 130: 598-604.
5. Tagami H, Tatsuta K, Iwatski K, Yamada M. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol 1983: 119: 910-913.
6. Roujeau J C, Chosidow O, Saiag Ph, Guillaume J C. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990: 23: 1039-1057.
7. Roujeau J C, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991: 127: 1333-1338.
8. Alanko C. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993: 29: 254-257.
9. Bruynzeel D P, Van-Ketel W G. Patch testing in drug eruptions. Semin Dermatol 1989;: 8: 196-203.
10. Houwerzijl J, Gast G D, Nater J, Esselink T, Nieweg H. Lymphocyte-stimulation tests and patch tests in carbamazepine hypersensitivity. Clin Exp Immunol 1977: 29: 272-277.
11. Alanko C. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993: 29: 254-257.
12. Calkin J M, Maibach H I. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993: 29: 223-233.
13. Osawa J, Naito S, Aihara M et al. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 1990: 17: 235-239.
14. Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 198:; 125: 299.
|
Language: | English.
|
Document Type: | Original Article.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0105-1873
|
NLM Journal Code: | dp7, 7604950
|
Annotation(s) | |